2008: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's: Clinical Aspects and Therapeutics II
Search or Browse by Day

Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's: Clinical Aspects and Therapeutics II

Tuesday, October 28, 2008
1768
Effects Of Cyclophosphamide On Pulmonary Function In Patients With Scleroderma And Interstitial Lung Disease:a Systematic Review And A Meta-analysis Of Randomized Controlled Trials And Observational Prospective Cohort Studies
1769
Allogeneic Mesenchymal Stem Cell Transplantation in Progressive Systemic Sclerosis
1770
Long-Term Outcome with First-Line Bosentan Therapy in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
1771
Molecular Framework for Response to Imatinib Mesylate in Systemic Sclerosis
1772
Bronchoalveolar Lavage and Response to Cyclophosphamide in Scleroderma Alveolitis
1773
Phase III Open-Label Study of Topical Nitroglycerin , MQX-503, in the Treatment and Prevention of Raynaud’s Phenomenon
1774
Safety and Tolerability of MQX-503, a Novel Investigational Topical Formulation of Nitroglycerin for the Treatment of Raynaud’s Phenomenon
1775
Sclerodermatous Syndrome After Allogenic Hematopoietic Stem Cell Transplantation (HSCT)
1776
Sarpogrelate Hydrochloride Therapy For Raynaud’S Phenomenon In Patients With Systemic Sclerosis
1777
Phosphodiesterase Inhibitor Tadalafil In The Treatment Of Ischemic Digital Ulcers/digital Necrosis Due To Scleroderma-associated Raynaud’S Phenomenon
1778
Comparison Of Responders And Non-responders To MQX-503, A Novel Investigational Topical Nitroglycerin Formulation, In Treatment Of Scleroderma-related And Non-scleroderma-related Raynaud’S Phenomenon
1779
Rituximab for the Long Term Treatment of Severe Cutaneous Involvement in Systemic Sclerosis
1780
Use Of Hydrobalance® Dressing In Scleroderma Ulcers
1781
Systemic Sclerosis bone marrow-derived Mesenchymal Stem Cells: differential expression of VEGF/VEGFRs, SDF1/CXCR4 and TGFbeta/TGFbetaRs
1782
Assessment Of Vitamin D Deficiency And Insufficiency In 2 Independent Cohorts Of Patients With Systemic Sclerosis
1783
Neuro-Gastric Interactions: Prolonged Transcutaneous Electrical Nerve Stimulation (TENS) Treatment Demonstrated Improved Gastric Functioning by Electrogastrography, Pain Scores, Plasma VIP and IL-6 Levels in Systemic Sclerosis (SSc) Patients
1784
Predicting the course of %FVC: Lessons learned in the Scleroderma Lung Study (SLS)
1785
Bosentan for Digital Ulcers in Patients with Systemic Sclerosis. A Prospective 3-Year Follow-up study
1786
Clinical, Endoscopic, Manometric, Histologic Findings In The Gastro-esophageal Tract And Prevalence Of Helicobacter Pylori In Patients With Systemic Sclerosis
1787
Increased Systemic Sclerosis Disease Duration is Associated with Increased Left Ventricular Diastolic Stiffness
1788
Clinical Signs and Symptoms Associated with Pain in Patients with Systemic Sclerosis
1789
Prevalence and significance of associated auto-immune diseases in two large cohorts of European Caucasian patients with Systemic Sclerosis
1790
Improvement of Pulmonary Function Studies in Patients with Early Diffuse Systemic Sclerosis Without Clinical Symptoms of Pulmonary Involvement Six Months After Initiation ofMycophenolate Mofetil: A Prospective Open Label Study
1791
Assessment of Reproductive History in Systemic Sclerosis
1792
Cigarette Smoking as a Significant Risk Factor for Vascular and Gastrointestinal Disease in Patients with Systemic Sclerosis
1793
An Alternative Method of Measuring Finger Joint Contracture in Systemic Sclerosis (SSc)
1794
18F-FDG PET/CT In The Study Of Lung Involvement In Patients With Systemic Sclerosis (ssc)
1795
Disease activity criteria for patients with early Systemic Sclerosis
1796
A Three Month Prospective Study of Changes in Nailfold Capillary Architecture with Time
1797
Outcome Of Pregnancies In Systemic Sclerosis: A Retrospective Analysis Of 400 Hungarian Patients
1798
Prevalence of Obstructive Sleep Apnea in Patients with Connective Tissue Disease and Pulmonary Hypertension
1799
Elevated Plasma Adrenomedullin And Vascular Manifestations In Patients With Systemic Sclerosis
1800
Proteomic Identification Of Target Antigens Of Anti-fibroblast Antibodies In Patients With Idiopathic And Systemic Sclerosis-associated Pulmonary Arterial Hypertension
1801
ARTICULAR INVOLVEMENT IN SYSTEMIC SCLEROSIS (SSc)Ultrasonographic Features of The Scleroderma Hand As Compared With Clinical And X-ray Findings
See more of: ACR Abstract Submission Poster Sessions
<< Previous Session Level | Next Session Level >>